マサチューセッツ州における大うつ病性障害の臨床試験
マサチューセッツ州内の拠点で、大うつ病性障害に関する45件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Watertown
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Watertown
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/10/01更新 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Adams Clinical LLC, Watertown
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/25更新 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Activmed Practices & Research, Llc - Methuen, Methuen
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Boston Childrens Hospital, Boston
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/25更新 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Boston, Boston
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Boston
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/24更新 · NCT06830044The Medically Tailored Groceries and Mental Health Study
- UMass Chan Medical School, Worcester
- Community Care Cooperative (C3), Worcester
- UMass Memorial Health, Worcester
被験者募集中
18歳以上 · 全性別 · 2026/09/22更新 · NCT07779707Accelerated TMS for Perinatal Depression
- Brigham and Women's Hospital, Boston
被験者募集中
18歳〜55歳 · 女性 · 2026/09/18更新 · NCT06968390A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Boston
- Seaport Investigator Site, Russells Mills
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Adams Clinical, Inc., Watertown
- Vitalix Clinical, Inc., Worcester
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Adams Clinical Boston, Boston
- Activmed Practices & Research, Llc - Methuen, Methuen
- Adams Clinical Watertown, Watertown
- 他1件
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/08更新 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Boston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/02更新 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
被験者募集中
22歳〜70歳 · 全性別 · 2026/08/28更新 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Watertown
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/26更新 · NCT07300969Home-Based tDCS Treatment Of Major Depressive Disorder
- Curavit Clinical Research (virtual study site), Boston
被験者募集中
22歳〜70歳 · 全性別 · 2026/08/14更新 · NCT06976697The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown
被験者募集中第3相
18歳〜55歳 · 全性別 · 2026/08/13更新 · NCT06247839A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Boston
- Vitalix Clinical, Worcester
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/10更新 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Boston, Boston
- K2 Medical Research - Foxborough, Foxborough
- Adams Clinical Watertown, Watertown
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Boston Clinical Trials Llc, Boston
- ELIXIA, Springfield
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Mayflower Clinical, Russells Mills
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/08/03更新 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Vitalix Clinical, Worcester
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/07/27更新 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Boston
- Neurocrine Clinical Site, Watertown
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Springfield
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/07/24更新 · NCT07484217Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Boston, Boston
- Adams Clinical, Watertown, Watertown
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT05800925Neural Correlates of Stress and Perceived Control in Adolescent Depression
- McLean Hospital, Belmont
被験者募集中健康なボランティア歓迎
14歳〜18歳 · 女性 · 2026/05/19更新 · NCT04788524Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
- Mclean Hospital, Belmont
被験者募集中第2相健康なボランティア歓迎
18歳〜45歳 · 全性別 · 2026/05/18更新 · NCT05232032Mechanisms Of Orbitofrontal Stimulation in Depression
- Beth Israel Deaconess Medical Center, Boston
被験者募集中
18歳〜65歳 · 全性別 · 2026/05/14更新 · NCT07230990Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
- McLean Hospital, Belmont
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/05/13更新 · NCT07560878A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Elixia MA, Springfield
- Adams Clinical, Watertown
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830Mindfulness-Based fMRI Neurofeedback for Depression
- Northeastern University, Boston
被験者募集中
13歳〜18歳 · 全性別 · 2026/04/29更新 · NCT05617495REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Lindus Health (Virtual Study Site), Boston
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/29更新 · NCT07280065Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- McLean Hospital, Belmont
- Beth Israel Deaconess Medical Center, Boston
被験者募集中観察研究
18歳〜40歳 · 全性別 · 2026/03/10更新 · NCT06740383Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
- Harvard Medical School, Boston
被験者募集中
18歳〜65歳 · 全性別 · 2026/02/05更新 · NCT05573074Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #137, Boston
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/01/20更新 · NCT06633016Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
- Massachusetts General Hospital, Boston
被験者募集中第4相
18歳〜70歳 · 全性別 · 2025/12/12更新 · NCT05450432Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Boston
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/29更新 · NCT06786624Stress Dynamics and Familial Risk for Depression in Female Adolescents
- McLean Hospital, Belmont
被験者募集中健康なボランティア歓迎
13歳〜15歳 · 女性 · 2025/10/23更新 · NCT06816329Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- McLean Hospital, Belmont
被験者募集中観察研究健康なボランティア歓迎
18歳〜45歳 · 全性別 · 2025/10/21更新 · NCT05630963Targeting Specific Brain Networks to Treat Specific Symptoms in Depression
- Massachusetts General Hospital, Boston
被験者募集中健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2025/09/29更新 · NCT05523817ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。